XTL Biopharmaceutica (Israel) Market Value
| XTLB Stock | ILS 9.30 0.10 1.06% |
| Symbol | XTL |
XTL Biopharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XTL Biopharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XTL Biopharmaceutica.
| 03/25/2024 |
| 04/24/2024 |
If you would invest 0.00 in XTL Biopharmaceutica on March 25, 2024 and sell it all today you would earn a total of 0.00 from holding XTL Biopharmaceuticals or generate 0.0% return on investment in XTL Biopharmaceutica over 30 days. XTL Biopharmaceutica is related to or competes with Nice, Bank Leumi, ICL Israel, Mizrahi Tefahot, Azrieli, Elbit Systems, and Israel Discount. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical p... More
XTL Biopharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XTL Biopharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XTL Biopharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.36 | |||
| Information Ratio | 0.1299 | |||
| Maximum Drawdown | 143.94 | |||
| Value At Risk | (9.71) | |||
| Potential Upside | 11.76 |
XTL Biopharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XTL Biopharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XTL Biopharmaceutica's standard deviation. In reality, there are many statistical measures that can use XTL Biopharmaceutica historical prices to predict the future XTL Biopharmaceutica's volatility.| Risk Adjusted Performance | 0.0938 | |||
| Jensen Alpha | 2.63 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.3888 | |||
| Treynor Ratio | (2.89) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of XTL Biopharmaceutica's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
XTL Biopharmaceuticals Backtested Returns
XTL Biopharmaceutica is dangerous given 3 months investment horizon. XTL Biopharmaceuticals shows Sharpe Ratio of 0.16, which attests that the company had a 0.16% return per unit of standard deviation over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 3.58% are justified by taking the suggested risk. Use XTL Biopharmaceuticals Downside Deviation of 6.36, mean deviation of 8.23, and Risk Adjusted Performance of 0.0938 to evaluate company specific risk that cannot be diversified away. XTL Biopharmaceutica holds a performance score of 12 on a scale of zero to a hundred. The firm maintains a market beta of -0.89, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning XTL Biopharmaceutica are expected to decrease slowly. On the other hand, during market turmoil, XTL Biopharmaceutica is expected to outperform it slightly. Use XTL Biopharmaceuticals treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to analyze future returns on XTL Biopharmaceuticals.
Auto-correlation | 0.69 |
Good predictability
XTL Biopharmaceuticals has good predictability. Overlapping area represents the amount of predictability between XTL Biopharmaceutica time series from 25th of March 2024 to 9th of April 2024 and 9th of April 2024 to 24th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XTL Biopharmaceuticals price movement. The serial correlation of 0.69 indicates that around 69.0% of current XTL Biopharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.49 |
XTL Biopharmaceuticals lagged returns against current returns
Autocorrelation, which is XTL Biopharmaceutica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XTL Biopharmaceutica's stock expected returns. We can calculate the autocorrelation of XTL Biopharmaceutica returns to help us make a trade decision. For example, suppose you find that XTL Biopharmaceutica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
XTL Biopharmaceutica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XTL Biopharmaceutica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XTL Biopharmaceutica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XTL Biopharmaceutica stock over time.
Current vs Lagged Prices |
| Timeline |
XTL Biopharmaceutica Lagged Returns
When evaluating XTL Biopharmaceutica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XTL Biopharmaceutica stock have on its future price. XTL Biopharmaceutica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XTL Biopharmaceutica autocorrelation shows the relationship between XTL Biopharmaceutica stock current value and its past values and can show if there is a momentum factor associated with investing in XTL Biopharmaceuticals.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards XTL Biopharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, XTL Biopharmaceutica's short interest history, or implied volatility extrapolated from XTL Biopharmaceutica options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out XTL Biopharmaceutica Correlation, XTL Biopharmaceutica Volatility and XTL Biopharmaceutica Alpha and Beta module to complement your research on XTL Biopharmaceutica. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.